T-cell Engineering

NICE Backs Obe-cel for Adults With Aggressive Leukaemia as NHS Fast-Tracks Rollout

NHS England will begin offering the UK‑developed CAR‑T within weeks through specialist centres using interim Cancer Drugs Fund support.